Tech Company Financing Transactions
ResoTher Pharma Funding Round
ResoTher Pharma, based in Holte, secured $2.7 million from European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
11/6/2023
Transaction Type
Venture Equity
Amount
$2,670,000
Round
Undisclosed
Investors
European Innovation Council Fund (Lead Investor)
Proceeds Purpose
The company will use the funds to support a Phase 2a clinical study of their Lead Candidate RTP-026 for Myocardial Infarction.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Dronninggaards Alle 136
Holte, 2840
DK
Holte, 2840
DK
Phone
Website
Email Address
Overview
ResoTher Pharma is a clinical stage biotechnology company located in Copenhagen, Denmark. We are on a mission to deliver new and effective treatment options for patients suffering from cardiovascular disease. Our peptide-based drugs address the pathological role of inflammation by acting as resolution therapy, terminating the inflammatory response and inducing regeneration in the affected tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anders Kronborg
Chief Financial Officer
Teis Vester
Browse more venture capital transactions:
Prev: 11/6/2023: Century Box venture capital transaction
Next: 11/6/2023: TapNation venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs